title: Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.
authors.forename: Arthur G
authors.initials: AG
authors.lastname: Pratt
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Charles
authors.forename: Muslima
authors.initials: M
authors.lastname: Chowdhury
authors.forename: Gillian
authors.initials: G
authors.lastname: Wilson
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Venables
authors.forename: John D
authors.initials: JD
authors.lastname: Isaacs
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D042241:Early Diagnosis; D005500:Follow-Up Studies; D006801:Humans; D010456:Peptides, Cyclic / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide